|
CYRX | Cryoport, Inc. |
|
|
CYRX | Cryoport, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 1.29 |
| Leverage | 34.29% |
| Market Cap | $ 389.8m |
| PE | 4.98 |
| Dividend Yield | 0.00% |
| Profit | $ 78.3m |
| Margin | 45.25% |
Cryoport, Inc., a life sciences services company, provides temperature controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Brentwood, Tennessee.